03:56 duration 3 minutes 56 seconds
Tafamidis treatment of transthyretin mediated…
Tafamidis treatment of transthyretin mediated amyloidosis (TTR) approved by FDA
Mazen Hanna, MD, Co-Director of the Cleveland Clinic’s Amyloidosis Center talks about the FDA’s recent approval of the drug Tafamidis for the treatment of ATTR Amyloidosis (also known as…